{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:14:09Z","timestamp":1790878449778,"version":"4.1.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"\n Background<\/jats:title>\n \n The COVID-19 pandemic caused by SARS-CoV-2 underscores the urgent need for novel antiviral agents. Preliminary screening indicated that the traditional Chinese medicine\n Siphonostegia chinensis<\/jats:italic>\n Benth. (Bei Liu Ji Nu) possesses inhibitory activity against the SARS-CoV-2 main protease (Mpro), a key enzyme for viral replication.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n To identify the active constituents responsible for its anti-SARS-CoV-2 activity, we employed an integrated strategy combining bio-layer interferometry (BLI) and ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Two phenolic compounds, verbascoside and 3,4-dicaffeoylquinic acid, were successfully fished out and identified from the ethanol extract as the most potent binders to Mpro. The binding affinities (KD) were determined to be 2.149 \u00d7 10\n \u22126<\/jats:sup>\n \u00a0M and 2.487 \u00d7 10\n \u22125<\/jats:sup>\n \u00a0M, respectively. Subsequent\n in vitro<\/jats:italic>\n enzymatic inhibition assays confirmed their inhibitory effects, with IC\n 50<\/jats:sub>\n values of 0.076\u00a0\u00b5M and 0.194 \u00b5M, respectively. To elucidate the inhibition mechanism, molecular docking and molecular dynamics simulations were performed, revealing stable binding modes of both compounds within the catalytic pocket of Mpro through key interactions. Preliminary ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) predictions were also conducted to assess their drug-likeness.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Our findings demonstrate that verbascoside and 3,4-dicaffeoylquinic acid exhibit high binding affinity and structural stability against SARS-CoV-2 Mpro, highlighting their potential as lead compounds for inhibiting viral replication. Furthermore, the comprehensive strategy established in this study provides a reliable and efficient approach for identifying bioactive components from complex herbal matrices, offering new perspectives and a scientific basis for the development of natural product-derived targeted therapeutics.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fchem.2026.1790228","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:23:51Z","timestamp":1775820231000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["SARS-CoV-2 Mpro inhibitors from Siphonostegia chinensis: an integrated biophysical and computational study"],"prefix":"10.3389","volume":"14","author":[{"given":"Yingjie","family":"Ren","sequence":"first","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Henan Province Engineering Research Center for Clinical Application, Evaluation and Transformation of Traditional Chinese Medicine, Henan Provincial Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine, Henan Province Engineering Research Center of Safety Evaluation and Risk Management of Traditional Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Disease Prevention and Control, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Henan Province Engineering Research Center for Clinical Application, Evaluation and Transformation of Traditional Chinese Medicine, Henan Provincial Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine, Henan Province Engineering Research Center of Safety Evaluation and Risk Management of Traditional Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingliang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Henan Province Engineering Research Center for Clinical Application, Evaluation and Transformation of Traditional Chinese Medicine, Henan Provincial Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine, Henan Province Engineering Research Center of Safety Evaluation and Risk Management of Traditional Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"School of Pharmacy, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Henan Province Engineering Research Center for Clinical Application, Evaluation and Transformation of Traditional Chinese Medicine, Henan Provincial Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine, Henan Province Engineering Research Center of Safety Evaluation and Risk Management of Traditional Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Henan Province Engineering Research Center for Clinical Application, Evaluation and Transformation of Traditional Chinese Medicine, Henan Provincial Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine, Henan Province Engineering Research Center of Safety Evaluation and Risk Management of Traditional Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Henan Province Engineering Research Center for Clinical Application, Evaluation and Transformation of Traditional Chinese Medicine, Henan Provincial Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine, Henan Province Engineering Research Center of Safety Evaluation and Risk Management of Traditional Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuqing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Henan Province Engineering Research Center for Clinical Application, Evaluation and Transformation of Traditional Chinese Medicine, Henan Provincial Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine, Henan Province Engineering Research Center of Safety Evaluation and Risk Management of Traditional Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Henan Province Engineering Research Center for Clinical Application, Evaluation and Transformation of Traditional Chinese Medicine, Henan Provincial Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine, Henan Province Engineering Research Center of Safety Evaluation and Risk Management of Traditional Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Henan Province Engineering Research Center for Clinical Application, Evaluation and Transformation of Traditional Chinese Medicine, Henan Provincial Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine, Henan Province Engineering Research Center of Safety Evaluation and Risk Management of Traditional Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfa","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Henan Province Engineering Research Center for Clinical Application, Evaluation and Transformation of Traditional Chinese Medicine, Henan Provincial Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine, Henan Province Engineering Research Center of Safety Evaluation and Risk Management of Traditional Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"School of Pharmacy, Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqing","family":"Ren","sequence":"additional","affiliation":[{"name":"Hospital of Pediatrics, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Pediatric Medical College, Henan University of Traditional Chinese Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1007\/s10787-024-01525-9","article-title":"Taming the storm: potential anti-inflammatory compounds targeting SARS-CoV-2 MPro","volume":"32","author":"Anton","year":"2024","journal-title":"Inflammopharmacology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1642830","DOI":"10.3389\/fphar.2025.1642830","article-title":"Comparative assessment of antibacterial drugs used at the hospital level before and during COVID-19, according to the WHO AWaRe classification","volume":"16","author":"Balapasheva","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.drudis.2020.12.005","article-title":"Potential SARS-CoV-2 main protease inhibitors","volume":"26","author":"Banerjee","year":"2021","journal-title":"Drug Discov. Today"},{"key":"B5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41586-023-06609-0","article-title":"Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir","volume":"622","author":"Duan","year":"2023","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/prot.26814","article-title":"SARS-CoV-2 mpro dihedral angles reveal allosteric signaling","volume":"93","author":"Evans","year":"2025","journal-title":"Proteins"},{"key":"B8","doi-asserted-by":"publisher","first-page":"16922","DOI":"10.1021\/acs.jmedchem.1c00409","article-title":"Perspectives on SARS-CoV-2 main protease inhibitors","volume":"64","author":"Gao","year":"2021","journal-title":"J. Med. Chem."},{"key":"B9","first-page":"1782","article-title":"Study on fingerprint and content determination of Siphonostegia chinensis standard decoction","volume":"26","author":"Huang","year":"2024","journal-title":"Zhongguo Xiandai Zhongyao"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.819165","article-title":"Targeting SARS-CoV-2 proteases for COVID-19 antiviral development","volume":"9","author":"Lv","year":"2022","journal-title":"Front. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.3390\/ijms24043236","article-title":"Identification of SARS-CoV-2 main protease (Mpro) cleavage sites using two-dimensional electrophoresis and in silico cleavage site prediction","volume":"24","author":"Miltner","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1434181","DOI":"10.3389\/fphar.2024.1434181","article-title":"COVID-19 vaccines: current and future challenges","volume":"15","author":"Mohammadi","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"676451","DOI":"10.3389\/fcimb.2021.676451","article-title":"SARS-CoV-2: origin, evolution, and targeting inhibition. Front. Cell","volume":"11","author":"Ning","year":"2021","journal-title":"Infect. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"154858","DOI":"10.1016\/j.phymed.2023.154858","article-title":"Myricetin possesses the potency against SARS-CoV-2 infection through blocking viral-entry facilitators and suppressing inflammation in rats and mice","volume":"116","author":"Pan","year":"2023","journal-title":"Phytomedicine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"116704","DOI":"10.1016\/j.ejmech.2024.116704","article-title":"Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: insights into their design, classification, biological activity, and binding interactions","volume":"277","author":"Shawky","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s00894-023-05534-3","article-title":"Exploring potential SARS-CoV-2 Mpro non-covalent inhibitors through docking, pharmacophore profile matching, molecular dynamic simulation, and MM-GBSA","volume":"29","author":"Shi","year":"2023","journal-title":"J. Mol. Model."},{"key":"B16","doi-asserted-by":"publisher","first-page":"11739","DOI":"10.3390\/ijms222111739","article-title":"Natural products-based drug design against SARS-CoV-2 mpro 3CLpro","volume":"22","author":"Silva","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1654173","DOI":"10.3389\/fphar.2025.1654173","article-title":"Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: a retrospective cohort study","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/biom14070797","article-title":"Inhibitors of SARS-CoV-2 main protease (Mpro) as anti-coronavirus agents","volume":"14","author":"Zag\u00f3rska","year":"2024","journal-title":"Biomolecules"},{"key":"B20","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/pca.3462","article-title":"A biolayer interferometry-based SARS-COV-2 Mpro-Targeted active ingredients recognition system: construction and application in ligand screening from herbal medicines","volume":"36","author":"Zhang","year":"2025","journal-title":"Phytochem. Anal."},{"key":"B22","first-page":"2341","article-title":"Optimization of extraction process for Siphonostegia chinensis-Drynaria fortunei based on design space method","volume":"53","author":"Zhang","year":"2022","journal-title":"Zhongcaoyao"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1673591","DOI":"10.3389\/fphar.2025.1673591","article-title":"Evaluation of silvestrol as a potential therapeutic agent for pediatric COVID-19: an interpreted computational and phytochemistry approach","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1790228\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:23:52Z","timestamp":1775820232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1790228\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":22,"alternative-id":["10.3389\/fchem.2026.1790228"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2026.1790228","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"article-number":"1790228"}}